SENP2 anticorps (AA 1-100) (Cy3)
Aperçu rapide pour SENP2 anticorps (AA 1-100) (Cy3) (ABIN6983646)
Antigène
Voir toutes SENP2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-100
-
Réactivité croisée
- Souris
-
Homologie
- Human,Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human SENP2
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- SENP2 (SUMO1/sentrin/SMT3 Specific Peptidase 2 (SENP2))
-
Autre désignation
- SENP2
-
Sujet
-
Synonyms: AXAM2, SMT3IP2, Sentrin-specific protease 2, SMT3-specific isopeptidase 2, Sentrin/SUMO-specific protease SENP2, SENP2, KIAA1331
Background: Protease that catalyzes two essential functions in the SUMO pathway: processing of full-length SUMO1, SUMO2 and SUMO3 to their mature forms and deconjugation of SUMO1, SUMO2 and SUMO3 from targeted proteins. May down-regulate CTNNB1 levels and thereby modulate the Wnt pathway. Deconjugates SUMO2 from MTA1. Plays a dynamic role in adipogenesis by desumoylating and promoting the stabilization of CEBPB (PubMed:20194620).
-
ID gène
- 59343
-
UniProt
- Q9HC62
-
Pathways
- Chromatin Binding
Antigène
-